Neogen (NEOG) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Neogen (NEOG) Net Income towards Common Stockholders Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -22.27% |
| Feb 28, 2026 | -26.75% |
| Nov 30, 2025 | -24.59% |
| Aug 31, 2025 | 18.04% |
| May 31, 2025 | -111.03% |
| Feb 28, 2025 | -23.68% |
| Nov 30, 2024 | -97.48% |
| Aug 31, 2024 | -23.39% |
| May 31, 2024 | -18.56% |
| Feb 29, 2024 | -16.59% |
| Nov 30, 2023 | -17.26% |
| Aug 31, 2023 | -37.08% |
| May 31, 2023 | -18.31% |
| Feb 28, 2023 | -13.16% |
| Nov 30, 2022 | -34.73% |
| Aug 31, 2022 | -15.28% |
| May 31, 2022 | 2.62% |
| Feb 28, 2022 | -12.11% |
| Nov 30, 2021 | -0.62% |
| Aug 31, 2021 | 11.44% |